SCHEMBL7192542

SCHEMBL7192542

NC(C=O)c1ccc(O)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 9/20 0.50
▸ KDM4E B2RXH2 9/20 0.50
▸ RECQL P46063 7/20 0.50
▸ MAPT P10636 6/20 0.50
▸ BLM P54132 6/20 0.50
▸ LMNA P02545 5/20 0.50
▸ APEX1 P27695 3/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ADRA1A P35348 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ NFKB1 P19838 2/20 0.50
▸ THPO P40225 2/20 0.50
▸ HIF1A Q16665 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ MTOR P42345 1/20 0.50
▸ NR1I2 O75469 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ MAPK1 P28482 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20361608 1.00 TDP1 (0.50) TDP1KDM4ERECQLMAPTBLM
SCHEMBL10401988 0.79 TDP1 (0.50) TDP1KDM4ERECQLMAPTBLM
SCHEMBL13971487 0.79 TDP1 (0.59) TDP1KDM4ERECQLMAPTBLM
SCHEMBL13971484 0.79 TDP1 (0.59) TDP1KDM4ERECQLMAPTBLM
SCHEMBL7134776 0.78 ALDH1A1 (0.53) TDP1RECQLMAPTLMNAAPEX1
SCHEMBL18857794 0.77 TDP1 (0.58) TDP1KDM4ERECQLMAPTBLM
SCHEMBL29374017 0.77 TDP1 (0.48) TDP1KDM4ERECQLMAPTBLM
SCHEMBL1332823 0.77 TDP1 (0.48) TDP1KDM4ERECQLMAPTBLM
SCHEMBL7193441 0.76 ESR1 (0.42) TDP1KDM4ERECQLMAPTBLM
SCHEMBL12871736 0.76 ESR1 (0.42) TDP1KDM4ERECQLMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566355-B1 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens HOFFMANN-LA ROCHE INC. 2003-05-20 — — US disclosed
US-5712268-A Compositions of tricyclic β-lactams and uses thereof HOFFMANN-LA ROCHE INC. (US) 1998-01-27 — — US disclosed
US-5698577-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1997-12-16 — — US disclosed
EP-0508234-B1 Beta-lactames HOFFMANN LA ROCHE (CH) 1996-07-24 — — EP disclosed
US-5510343-A BETA-LACTAMASE INHIBITOR HOFFMANN-LA ROCHE INC. (US) 1996-04-23 — — US disclosed
EP-0508234-A2 Beta-lactames F. HOFFMANN-LA ROCHE AG (CH) 1992-10-14 — — EP disclosed
Send feedback